EMERGENT BIOSOLUTIONS INC. Earnings Per Share (Diluted)
EMERGENT BIOSOLUTIONS INC. (EBS) reported Earnings Per Share (Diluted) of -$3.49 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$3.49.
- EMERGENT BIOSOLUTIONS INC. earnings per share, diluted for the quarter ending 2026-03-31 was $0.07, a 94.12% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.96.
- EMERGENT BIOSOLUTIONS INC. earnings per share, diluted for the quarter ending 2025-09-30 was $0.91, a 55.83% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. earnings per share, diluted for fiscal 2025 was $0.93.
- EMERGENT BIOSOLUTIONS INC. earnings per share, diluted for fiscal 2024 was -$3.60.
- EMERGENT BIOSOLUTIONS INC. earnings per share, diluted for fiscal 2023 was -$14.85.
- EMERGENT BIOSOLUTIONS INC. earnings per share, diluted for fiscal 2022 was -$4.22, a 203.94% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.49 10-Q · filed 2026-08-06 | -$3.35 10-Q · filed 2026-08-06 | -$4.15 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.20 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2026-03-31 | $0.07 10-Q · filed 2026-05-01 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.06 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-12-31 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.93 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $0.91 10-Q · filed 2025-10-30 | $0.71 derived: net income ÷ weighted average shares · filed 2026-08-06 | $1.89 10-Q · filed 2025-10-30 | $1.37 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-06-30 | -$0.22 10-Q · filed 2026-08-06 | $0.99 10-Q · filed 2026-08-06 | $0.45 derived: net income ÷ weighted average shares · filed 2026-08-06 | $2.52 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-03-31 | $1.19 10-Q · filed 2026-05-01 | $0.66 derived: net income ÷ weighted average shares · filed 2026-08-06 | $2.72 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.40 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2024-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-02-27 | $1.52 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$3.69 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$3.60 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $2.06 10-Q · filed 2025-10-30 | -$3.11 derived: net income ÷ weighted average shares · filed 2025-10-30 | -$3.03 10-Q · filed 2025-10-30 | -$3.93 derived: net income ÷ weighted average shares · filed 2026-02-27 | ||||
| 2024-06-30 | -$5.38 10-Q · filed 2025-08-07 | -$5.23 10-Q · filed 2025-08-07 | -$6.19 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$11.25 derived: net income ÷ weighted average shares · filed 2026-02-27 | ||||
| 2024-03-31 | $0.17 10-Q · filed 2025-05-08 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$5.84 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$10.93 derived: net income ÷ weighted average shares · filed 2026-02-27 | ||||
| 2023-12-31 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$6.02 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$11.14 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$14.85 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | -$5.08 10-Q · filed 2024-11-07 | -$10.24 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$13.97 10-Q · filed 2024-11-07 | -$15.37 derived: net income ÷ weighted average shares · filed 2025-03-04 | ||||
| 2023-06-30 | -$5.16 10-Q · filed 2024-08-07 | -$5.15 10-Q · filed 2023-08-09 | -$8.86 10-Q · filed 2024-08-07 | -$8.80 10-Q · filed 2023-08-09 | -$10.24 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$12.00 derived: net income ÷ weighted average shares · filed 2025-03-04 | ||
| 2023-03-31 | -$3.71 10-Q · filed 2024-05-02 | -$3.65 10-Q · filed 2023-05-10 | -$5.06 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$6.81 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$7.87 derived: net income ÷ weighted average shares · filed 2025-03-04 | |||
| 2022-12-31 | -$1.34 10-K/A · filed 2023-12-11 | -$3.09 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$4.15 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$4.22 10-K · filed 2025-03-04 | -$4.47 10-K · filed 2023-03-01 | |||
| 2022-09-30 | -$1.75 10-K/A · filed 2023-12-11 | -$1.52 10-Q · filed 2022-11-09 | -$2.80 derived: net income ÷ weighted average shares · filed 2023-12-11 | -$2.88 10-Q · filed 2023-12-11 | -$2.71 10-Q · filed 2022-11-09 | $0.95 derived: net income ÷ weighted average shares · filed 2024-03-08 | ||
| 2022-06-30 | -$1.06 10-K/A · filed 2023-12-11 | -$1.13 10-Q · filed 2022-08-02 | -$1.19 10-Q · filed 2023-08-09 | $2.64 derived: net income ÷ weighted average shares · filed 2024-03-08 | $1.83 derived: net income ÷ weighted average shares · filed 2024-03-08 | |||
| 2022-03-31 | -$0.09 10-K/A · filed 2023-12-11 | -$0.07 10-Q · filed 2022-04-29 | $3.62 derived: net income ÷ weighted average shares · filed 2024-03-08 | $2.81 derived: net income ÷ weighted average shares · filed 2024-03-08 | $2.79 derived: net income ÷ weighted average shares · filed 2024-03-08 | |||
| 2021-12-31 | $3.60 10-K/A · filed 2023-12-11 | $2.85 derived: net income ÷ weighted average shares · filed 2024-03-08 | $2.83 derived: net income ÷ weighted average shares · filed 2024-03-08 | $4.06 10-K · filed 2024-03-08 | $4.27 10-K · filed 2022-02-25 | |||
| 2021-09-30 | -$0.75 10-K/A · filed 2023-12-11 | -$0.61 10-Q · filed 2021-11-05 | -$0.76 derived: net income ÷ weighted average shares · filed 2023-12-11 | $0.77 10-Q · filed 2022-11-09 | $3.91 derived: net income ÷ weighted average shares · filed 2023-12-11 | |||
| 2021-06-30 | -$0.01 10-K/A · filed 2023-12-11 | $0.09 10-Q · filed 2021-07-30 | $1.37 10-Q · filed 2022-08-02 | $4.64 derived: net income ÷ weighted average shares · filed 2023-12-11 | $5.37 derived: net income ÷ weighted average shares · filed 2023-12-11 | |||
| 2021-03-31 | $1.23 10-K/A · filed 2023-12-11 | $1.28 10-Q · filed 2021-04-30 | $4.64 derived: net income ÷ weighted average shares · filed 2023-12-11 | $5.37 derived: net income ÷ weighted average shares · filed 2023-12-11 | $7.10 derived: net income ÷ weighted average shares · filed 2023-12-11 | |||
| 2020-12-31 | $3.44 10-K · filed 2021-02-19 | $4.14 derived: net income ÷ weighted average shares · filed 2023-12-11 | $5.87 derived: net income ÷ weighted average shares · filed 2023-12-11 | $5.68 10-K/A · filed 2023-12-11 | $5.67 10-K · filed 2021-02-19 | |||
| 2020-09-30 | $0.73 10-Q · filed 2021-11-05 | $2.45 derived: net income ÷ weighted average shares · filed 2021-11-05 | $2.23 10-Q · filed 2021-11-05 | $3.14 derived: net income ÷ weighted average shares · filed 2022-02-25 | ||||
| 2020-06-30 | $1.73 10-Q · filed 2021-07-30 | $1.51 10-Q · filed 2021-07-30 | $2.41 derived: net income ÷ weighted average shares · filed 2022-02-25 | $3.24 derived: net income ÷ weighted average shares · filed 2022-02-25 | ||||
| 2020-03-31 | -$0.24 10-Q · filed 2021-04-30 | $0.66 derived: net income ÷ weighted average shares · filed 2022-02-25 | $1.48 derived: net income ÷ weighted average shares · filed 2022-02-25 | $1.31 derived: net income ÷ weighted average shares · filed 2022-02-25 | ||||
| 2019-12-31 | $0.90 10-K · filed 2021-02-19 | $1.72 derived: net income ÷ weighted average shares · filed 2022-02-25 | $1.55 derived: net income ÷ weighted average shares · filed 2022-02-25 | $1.04 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $0.83 10-K · filed 2021-02-19 | $0.65 derived: net income ÷ weighted average shares · filed 2021-02-19 | $0.15 10-Q · filed 2020-11-06 | $0.08 derived: net income ÷ weighted average shares · filed 2021-02-19 | ||||
| 2019-06-30 | -$0.18 10-K · filed 2021-02-19 | -$0.69 10-Q · filed 2020-07-31 | -$0.76 derived: net income ÷ weighted average shares · filed 2021-02-19 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-02-19 | ||||
| 2019-03-31 | -$0.51 10-K · filed 2021-02-19 | -$0.57 derived: net income ÷ weighted average shares · filed 2021-02-19 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-02-19 | $0.81 derived: net income ÷ weighted average shares · filed 2021-02-19 | ||||
| 2018-12-31 | -$0.07 10-K · filed 2020-02-25 | $0.34 derived: net income ÷ weighted average shares · filed 2021-02-19 | $1.31 derived: net income ÷ weighted average shares · filed 2021-02-19 | $1.22 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $0.41 10-K · filed 2020-02-25 | $1.38 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.29 10-Q · filed 2019-11-07 | $1.97 derived: net income ÷ weighted average shares · filed 2020-02-25 | ||||
| 2018-06-30 | $0.98 10-K · filed 2020-02-25 | $0.89 10-Q · filed 2019-08-02 | $1.57 derived: net income ÷ weighted average shares · filed 2020-02-25 | $2.23 derived: net income ÷ weighted average shares · filed 2020-02-25 | ||||
| 2018-03-31 | -$0.10 10-K · filed 2020-02-25 | $0.58 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.24 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.34 derived: net income ÷ weighted average shares · filed 2020-02-25 | ||||
| 2017-12-31 | $0.67 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.33 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.43 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.71 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $0.68 10-Q · filed 2018-11-02 | $0.76 derived: net income ÷ weighted average shares · filed 2018-11-02 | $1.03 10-Q · filed 2018-11-02 | $1.71 derived: net income ÷ weighted average shares · filed 2019-02-22 | ||||
| 2017-06-30 | $0.11 10-Q · filed 2018-08-03 | $0.35 10-Q · filed 2018-08-03 | $1.05 derived: net income ÷ weighted average shares · filed 2019-02-22 | $1.48 derived: net income ÷ weighted average shares · filed 2019-02-22 | ||||
| 2017-03-31 | $0.23 10-Q · filed 2018-05-04 | $0.95 derived: net income ÷ weighted average shares · filed 2019-02-22 | $1.39 derived: net income ÷ weighted average shares · filed 2019-02-22 | $1.23 derived: net income ÷ weighted average shares · filed 2019-02-22 | ||||
| 2016-12-31 | $0.77 10-K · filed 2018-02-23 | $1.17 derived: net income ÷ weighted average shares · filed 2019-02-22 | $1.02 derived: net income ÷ weighted average shares · filed 2019-02-22 | $1.13 10-K · filed 2019-02-22 | ||||
| 2016-09-30 | $0.45 10-K · filed 2018-02-23 | $0.23 derived: net income ÷ weighted average shares · filed 2017-11-03 | $0.36 10-Q · filed 2017-11-03 | $1.03 derived: net income ÷ weighted average shares · filed 2018-02-23 | ||||
| 2016-06-30 | -$0.27 10-K · filed 2018-02-23 | -$0.10 10-Q · filed 2017-08-04 | -$0.17 10-Q · filed 2016-08-05 | $0.58 derived: net income ÷ weighted average shares · filed 2018-02-23 | $1.37 derived: net income ÷ weighted average shares · filed 2018-02-23 | |||
| 2016-03-31 | $0.10 10-K · filed 2018-02-23 | $0.77 derived: net income ÷ weighted average shares · filed 2018-02-23 | $1.54 derived: net income ÷ weighted average shares · filed 2018-02-23 | $1.84 derived: net income ÷ weighted average shares · filed 2018-02-23 | ||||
| 2015-12-31 | $0.71 10-K · filed 2017-02-28 | $1.47 derived: net income ÷ weighted average shares · filed 2018-02-23 | $1.77 derived: net income ÷ weighted average shares · filed 2018-02-23 | $1.41 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $0.79 10-K · filed 2017-02-28 | $1.07 derived: net income ÷ weighted average shares · filed 2016-11-09 | $0.69 10-Q · filed 2016-11-09 | $1.18 derived: net income ÷ weighted average shares · filed 2017-02-28 | ||||
| 2015-06-30 | $0.32 10-K · filed 2017-02-28 | -$0.19 10-Q · filed 2016-08-05 | $0.44 derived: net income ÷ weighted average shares · filed 2017-02-28 | $0.88 derived: net income ÷ weighted average shares · filed 2017-02-28 | ||||
| 2015-03-31 | -$0.57 10-K · filed 2017-02-28 | $0.16 derived: net income ÷ weighted average shares · filed 2017-02-28 | $0.59 derived: net income ÷ weighted average shares · filed 2017-02-28 | $0.74 derived: net income ÷ weighted average shares · filed 2017-02-28 | ||||
| 2014-12-31 | $0.66 10-K · filed 2016-02-29 | $0.89 derived: net income ÷ weighted average shares · filed 2017-02-28 | $1.11 derived: net income ÷ weighted average shares · filed 2017-02-28 | $0.88 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $0.49 10-K · filed 2016-02-29 | $0.63 derived: net income ÷ weighted average shares · filed 2016-02-29 | $0.17 10-Q · filed 2015-11-06 | $0.55 derived: net income ÷ weighted average shares · filed 2016-02-29 | ||||
| 2014-06-30 | $0.13 10-K · filed 2016-02-29 | -$0.41 10-Q · filed 2015-08-06 | $0.00 derived: net income ÷ weighted average shares · filed 2016-02-29 | $0.36 derived: net income ÷ weighted average shares · filed 2016-02-29 | ||||
| 2014-03-31 | -$0.55 10-K · filed 2016-02-29 | -$0.13 derived: net income ÷ weighted average shares · filed 2016-02-29 | $0.23 derived: net income ÷ weighted average shares · filed 2016-02-29 | $0.51 derived: net income ÷ weighted average shares · filed 2016-02-29 | ||||
| 2013-12-31 | $0.41 10-K · filed 2015-03-09 | $0.77 derived: net income ÷ weighted average shares · filed 2016-02-29 | $1.06 derived: net income ÷ weighted average shares · filed 2016-02-29 | $0.85 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $0.36 10-K · filed 2015-03-09 | $0.65 derived: net income ÷ weighted average shares · filed 2015-03-09 | $0.44 10-Q · filed 2014-11-10 | $0.88 derived: net income ÷ weighted average shares · filed 2015-03-09 | ||||
| 2013-06-30 | $0.29 10-K · filed 2015-03-09 | $0.07 10-Q · filed 2014-08-08 | $0.51 derived: net income ÷ weighted average shares · filed 2015-03-09 | $0.69 derived: net income ÷ weighted average shares · filed 2015-03-09 | ||||
| 2013-03-31 | -$0.22 10-K · filed 2015-03-09 | $0.22 derived: net income ÷ weighted average shares · filed 2015-03-09 | $0.40 derived: net income ÷ weighted average shares · filed 2015-03-09 | $0.61 derived: net income ÷ weighted average shares · filed 2015-03-09 | ||||
| 2012-12-31 | $0.44 10-K · filed 2014-03-10 | $0.62 derived: net income ÷ weighted average shares · filed 2015-03-09 | $0.83 derived: net income ÷ weighted average shares · filed 2015-03-09 | $0.65 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $0.18 10-K · filed 2014-03-10 | $0.39 derived: net income ÷ weighted average shares · filed 2014-03-10 | $0.20 10-Q · filed 2013-11-08 | $0.98 derived: net income ÷ weighted average shares · filed 2014-03-10 | ||||
| 2012-06-30 | $0.21 10-K · filed 2014-03-10 | $0.02 10-Q · filed 2013-08-06 | $0.80 derived: net income ÷ weighted average shares · filed 2014-03-10 | $0.84 derived: net income ÷ weighted average shares · filed 2014-03-10 | ||||
| 2012-03-31 | -$0.19 10-K · filed 2014-03-10 | $0.59 derived: net income ÷ weighted average shares · filed 2014-03-10 | $0.63 derived: net income ÷ weighted average shares · filed 2014-03-10 | $1.02 derived: net income ÷ weighted average shares · filed 2014-03-10 | ||||
| 2011-12-31 | $0.78 10-K · filed 2013-03-08 | $0.81 derived: net income ÷ weighted average shares · filed 2014-03-10 | $1.20 derived: net income ÷ weighted average shares · filed 2014-03-10 | $0.64 10-K · filed 2014-03-10 | ||||
| 2011-09-30 | $0.04 10-K · filed 2013-03-08 | $0.43 derived: net income ÷ weighted average shares · filed 2013-03-08 | -$0.16 10-Q · filed 2012-11-01 | $0.58 derived: net income ÷ weighted average shares · filed 2013-03-08 | ||||
| 2011-06-30 | $0.39 10-K · filed 2013-03-08 | -$0.20 10-Q · filed 2012-08-03 | $0.54 derived: net income ÷ weighted average shares · filed 2013-03-08 | $0.93 derived: net income ÷ weighted average shares · filed 2013-03-08 | ||||
| 2011-03-31 | -$0.61 10-K · filed 2013-03-08 | $0.14 derived: net income ÷ weighted average shares · filed 2013-03-08 | $0.53 derived: net income ÷ weighted average shares · filed 2013-03-08 | $0.83 derived: net income ÷ weighted average shares · filed 2013-03-08 | ||||
| 2010-12-31 | $0.76 derived: net income ÷ weighted average shares · filed 2013-03-08 | $1.18 derived: net income ÷ weighted average shares · filed 2013-03-08 | $1.49 derived: net income ÷ weighted average shares · filed 2013-03-08 | $1.59 10-K · filed 2013-03-08 | ||||
| 2010-09-30 | $0.41 10-Q · filed 2011-11-04 | $0.72 derived: net income ÷ weighted average shares · filed 2011-11-04 | $0.80 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $0.31 10-Q · filed 2011-08-05 | $0.39 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $0.99 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |